tranexamic acid has been researched along with Chronic Disease in 21 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind study with tranexamic acid (Cyklokapron) was carried out in 17 patients with chronic urticaria." | 9.04 | Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study. ( Laurberg, G, 1977) |
| "Tranexamic acid (TA) used in a variety of conditions associated with bleeding has been associated with potential thrombotic side effects such as formation of thrombi and pulmonary embolism (PE)." | 7.77 | Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid. ( Krivokuca, I; Lammers, JW, 2011) |
| "The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 5.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
| "An 82-year-old female with a history of aortic dissection was admitted to our hospital for evaluation of thrombocytopenia and a bleeding tendency." | 5.39 | [Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection]. ( Hirano, T; Morikawa, K; Tsuda, H; Tsuji, T; Yamasaki, H, 2013) |
| "A double-blind study with tranexamic acid (Cyklokapron) was carried out in 17 patients with chronic urticaria." | 5.04 | Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study. ( Laurberg, G, 1977) |
| " It is not possible to determine whether human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate are effective or harmful for patients presenting with DIC related to acute or chronic leukemia." | 4.91 | Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. ( Anand, V; Martí-Carvajal, AJ; Solà, I, 2015) |
| " It is not possible to determine whether human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate are effective or harmful for patients presenting with DIC related to acute or chronic leukemia." | 4.87 | Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. ( Cardona, AF; Martí-Carvajal, AJ; Simancas, D, 2011) |
| "Tranexamic acid (TA) used in a variety of conditions associated with bleeding has been associated with potential thrombotic side effects such as formation of thrombi and pulmonary embolism (PE)." | 3.77 | Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid. ( Krivokuca, I; Lammers, JW, 2011) |
| " We present a case of postmenopausal bleeding, because of chronic DIC, which resulted from aortic aneurysm and was managed with replacement blood products and tranexamic acid." | 3.72 | Postmenopausal bleeding due to chronic DIC. ( Bollapragada, SS; Garg, M; McFarlane, T, 2004) |
| "Tranexamic acid is an antifibrinolytic that is known to reduce operative bleeding." | 2.78 | Intravenous tranexamic acid and intraoperative visualization during functional endoscopic sinus surgery: a double-blind randomized controlled trial. ( Chiarella, A; Côté, DW; Dziegielewski, PT; Langille, MA; Mulholland, G; Sowerby, LJ; Wright, ED, 2013) |
| "Gingival hemorrhage is recognized as a symptom of MDS, a rare group of potentially fatal hematological disorders, but it has not previously been documented as a presenting sign." | 2.40 | Gingival hemorrhage, myelodysplastic syndromes, and acute myeloid leukemia. A case report. ( Chapple, IL; Murray, JA; Saxby, MS, 1999) |
| "The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 1.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
| "Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients, which should be managed as invasive aspergillosis." | 1.43 | Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. ( Ader, F; Beigelman-Aubry, C; Blot, S; Cadranel, J; Chakrabarti, A; Denning, DW; Dimopoulos, G; Lange, C; Ullmann, AJ, 2016) |
| "An 82-year-old female with a history of aortic dissection was admitted to our hospital for evaluation of thrombocytopenia and a bleeding tendency." | 1.39 | [Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection]. ( Hirano, T; Morikawa, K; Tsuda, H; Tsuji, T; Yamasaki, H, 2013) |
| "Though her hemoptysis improved, respiratory failure suddenly worsened." | 1.33 | [A case of acute exacerbation of chronic pulmonary thromboembolism with essential thrombocythemia during treatment for hemoptysis]. ( Abe, T; Haraguchi, M; Hayashi, M; Ito, K; Nakajima, H; Sakagami, T; Tsutsui, N, 2006) |
| "Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions." | 1.26 | Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. ( Andersson, L; Eriksson, O; Hedlund, PO; Kjellman, H; Lindqvist, B, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 13 (61.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatate, Y | 1 |
| Masaki, N | 1 |
| Sato, A | 1 |
| Yasuda, R | 1 |
| Namba, T | 1 |
| Yada, H | 1 |
| Kawamura, A | 1 |
| Adachi, T | 1 |
| Magen, E | 1 |
| Chikovani, T | 1 |
| Tsuji, T | 1 |
| Morikawa, K | 1 |
| Hirano, T | 1 |
| Yamasaki, H | 1 |
| Tsuda, H | 1 |
| Jahanshahi, J | 1 |
| Hashemian, F | 1 |
| Pazira, S | 1 |
| Bakhshaei, MH | 1 |
| Farahani, F | 1 |
| Abasi, R | 1 |
| Poorolajal, J | 1 |
| Izvin, AI | 1 |
| Kuznetsova, NE | 1 |
| Siniakov, AIu | 1 |
| Martí-Carvajal, AJ | 2 |
| Anand, V | 1 |
| Solà, I | 1 |
| Denning, DW | 1 |
| Cadranel, J | 1 |
| Beigelman-Aubry, C | 1 |
| Ader, F | 1 |
| Chakrabarti, A | 1 |
| Blot, S | 1 |
| Ullmann, AJ | 1 |
| Dimopoulos, G | 1 |
| Lange, C | 1 |
| Desborough, M | 1 |
| Hadjinicolaou, AV | 1 |
| Chaimani, A | 1 |
| Trivella, M | 1 |
| Vyas, P | 1 |
| Doree, C | 1 |
| Hopewell, S | 1 |
| Stanworth, SJ | 1 |
| Estcourt, LJ | 1 |
| Krivokuca, I | 1 |
| Lammers, JW | 1 |
| Van Sickels, NJ | 1 |
| Hunsaker, RB | 1 |
| Van Sickels, JE | 1 |
| Asero, R | 1 |
| Tedeschi, A | 1 |
| Cugno, M | 1 |
| Simancas, D | 1 |
| Cardona, AF | 1 |
| Langille, MA | 1 |
| Chiarella, A | 1 |
| Côté, DW | 1 |
| Mulholland, G | 1 |
| Sowerby, LJ | 1 |
| Dziegielewski, PT | 1 |
| Wright, ED | 1 |
| Bollapragada, SS | 1 |
| Garg, M | 1 |
| McFarlane, T | 1 |
| Amarapurkar, DN | 1 |
| Patel, ND | 1 |
| Abe, T | 1 |
| Hayashi, M | 1 |
| Sakagami, T | 1 |
| Tsutsui, N | 1 |
| Ito, K | 1 |
| Nakajima, H | 1 |
| Haraguchi, M | 1 |
| Chapple, IL | 1 |
| Saxby, MS | 1 |
| Murray, JA | 1 |
| Laurberg, G | 1 |
| Tant, D | 1 |
| Andersson, L | 1 |
| Eriksson, O | 1 |
| Hedlund, PO | 1 |
| Kjellman, H | 1 |
| Lindqvist, B | 1 |
| Tomeoku, M | 1 |
| Nakase, T | 1 |
| Morita, K | 1 |
| Katou, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery: A Double-Blind Randomized Controlled Trial[NCT04863339] | Phase 2 | 0 participants (Actual) | Interventional | 2022-03-31 | Withdrawn (stopped due to Challenges in recruitment) | ||
| Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA) in Chinese Patients -Multicenter Study[NCT03027089] | 560 participants (Anticipated) | Observational | 2017-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for tranexamic acid and Chronic Disease
| Article | Year |
|---|---|
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagula | 2015 |
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Topics: Benzoates; Bone Marrow Diseases; Chronic Disease; Deamino Arginine Vasopressin; Hemorrhage; Hemostat | 2016 |
Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care.
Topics: Acute Disease; Adult; Airway Obstruction; Aminocaproic Acid; Androgens; Angioedemas, Hereditary; Ant | 2010 |
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagula | 2011 |
Gingival hemorrhage, myelodysplastic syndromes, and acute myeloid leukemia. A case report.
Topics: Acute Disease; Biopsy, Needle; Bone Marrow Cells; Chronic Disease; Diagnosis, Differential; Gingival | 1999 |
3 trials available for tranexamic acid and Chronic Disease
| Article | Year |
|---|---|
Effect of topical tranexamic acid on bleeding and quality of surgical field during functional endoscopic sinus surgery in patients with chronic rhinosinusitis: a triple blind randomized clinical trial.
Topics: Administration, Topical; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Chronic D | 2014 |
Intravenous tranexamic acid and intraoperative visualization during functional endoscopic sinus surgery: a double-blind randomized controlled trial.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Chemotherapy, | 2013 |
Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Double-Blind Method; | 1977 |
13 other studies available for tranexamic acid and Chronic Disease
| Article | Year |
|---|---|
Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Disseminated Int | 2017 |
Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.
Topics: Adult; Angioedema; Anti-Allergic Agents; Antifibrinolytic Agents; Chronic Disease; Female; Humans; I | 2018 |
[Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection].
Topics: Aged, 80 and over; Antifibrinolytic Agents; Aortic Dissection; Chronic Disease; Disseminated Intrava | 2013 |
[A rare case of thalassemia concomitant with chronic decompensated tonsillitis].
Topics: Adolescent; Anemia, Hypochromic; Antifibrinolytic Agents; Chemoprevention; Chronic Disease; Female; | 2014 |
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Topics: Antifibrinolytic Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bronchial Arte | 2016 |
Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid.
Topics: Antifibrinolytic Agents; Chronic Disease; Female; Hemoptysis; Humans; Middle Aged; Pulmonary Embolis | 2011 |
Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Cetirizine; Chr | 2010 |
Postmenopausal bleeding due to chronic DIC.
Topics: Aged; Aortic Aneurysm; Blood Transfusion; Chronic Disease; Disseminated Intravascular Coagulation; F | 2004 |
Gastric antral vascular ectasia (GAVE) syndrome.
Topics: Aged; Anemia, Iron-Deficiency; Chronic Disease; Disease Progression; Female; Gastric Antral Vascular | 2004 |
[A case of acute exacerbation of chronic pulmonary thromboembolism with essential thrombocythemia during treatment for hemoptysis].
Topics: Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Chronic Disease; Female; Hemoptysis; Humans; Ox | 2006 |
Tranexamic acid in chronic urticaria.
Topics: Chronic Disease; Cyclohexanecarboxylic Acids; Humans; Tranexamic Acid; Urticaria | 1979 |
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
Topics: Biological Availability; Chronic Disease; Creatinine; Cyclohexanecarboxylic Acids; Glomerulonephriti | 1978 |
[Chronic disseminated intravascular coagulation due to abdominal true aneurysm in two cases--effect of anti-platelet and anti-fibrinolytic therapy].
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Chronic Disease; Cyclohexanecarboxylic Acids; Disseminated | 1989 |